@entity566 is a significant problem in as much as 60% of @entity1 seeking care at an otolaryngologist's office. This raises the issue of the most effective means of diagnosing @entity566 , especially in pediatric @entity1 , who often may not tolerate skin testing. The RAST and CAP (Pharmacia) tests have been shown to be quite comparable with skin testing in diagnosing @entity566 . This study was undertaken to assess the effectiveness of treatment of @entity1 with @entity566 who had undergone in vitro testing. This was done by obtaining subjective symptom scores both before and after treatment. These were obtained from @entity1 with different in vitro results, including some with negative testing. Overall, 77 of 155 mailed questionnaires were returned. Results showed overall improvement of 38.81 points in 12 symptoms (p = 0.001; n = 62). Each symptom was rated on a visual scale of 1 to 10. A small portion of the @entity1 population received surgical treatment (tympanostomy tube placement with or without adenoidectomy) in addition to medical treatment and avoidance. These @entity1 did not have significantly higher pretreatment scores and did not have a higher improvement rate for all symptoms. We believe this study shows the validity of in vitro testing and treatment of @entity566 in @entity1 .

Diagnosing and treating pediatric XXXX .

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'patient'] @entity566 :: ('MESH:D006967', 'Disease') :: ['allergy', 'Allergy', 'allergies']
@entity566 :: (MESH:D006967,Disease) :: ['allergy']
